Davide Leone & Partners Investment CO Ltd. Uni Qure N.V. Transaction History

Davide Leone & Partners Investment CO Ltd.

$0
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$29.97 - $37.17 $1.74 Million - $2.16 Million	-58,044 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$29.24 - $42.03 $681,496 - $979,593	23,307 Added 67.1%	58,044 $1.96 Million
Q4 2020 Feb 16, 2021	BUY	$35.35 - $50.67 $1.23 Million - $1.76 Million	34,737 New	34,737 $1.26 Million

Others Institutions Holding QURE

# of Institutions

153

Shares Held

41M

Call Options Held

925K

Put Options Held

617K

Vestal Point Capital, LP New York, NY

4.75M
Shares

$27.5 Million
1.78% of portfolio
Nantahala Capital Management, LLC New Canaan, CT

2.78M
Shares

$16.1 Million
0.81% of portfolio
Boxer Capital, LLC San Diego, CA

2.23M
Shares

$12.9 Million
0.58% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

2.19M
Shares

$12.7 Million
0.01% of portfolio
Abrdn PLC

1.93M
Shares

$11.1 Million
0.02% of portfolio

View Full List

About uniQure N.V.

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $270M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

More about QURE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Davide Leone & Partners Investment CO Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Davide Leone & Partners Investment CO Ltd. with notifications on news.

Account